ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1961

Salivary and Lacrimal Glands Ultrasonography in Systemic Lupus Erythematosus Patients

Mohammadrafi Damirchi1, Nafiseh Abdolahi2, Fatemeh Hosseini3, Mohadeseh Mohammadi3, Mina Khosravi4, Zahra Niakan1 and Siavash Abbasi3, 1Golestan Rheumatology Research Center, Golestan University of Medical Sciences, Gorgan, Iran, Gorgan, Iran, 2Golestan Rheumatology Research Center, Golestan University of Medical Sciences, Gorgan, Iran, Melbourne, Australia, 3Department of Radiology, Golestan University of Medical Sciences, Gorgan, Iran, Gorgan, Iran, 4Faculty of Medicine, Iran University of Medical Sciences, Tehran, Iran, Tehran, Iran

Meeting: ACR Convergence 2024

Keywords: Eye Disorders, Sjögren's syndrome, Systemic lupus erythematosus (SLE), Ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 18, 2024

Title: Imaging of Rheumatic Diseases Poster II

Session Type: Poster Session C

Session Time: 10:30AM-12:30PM

Background/Purpose: Systemic Lupus Erythematosus (SLE) is an autoimmune inflammatory condition that can manifest in various ways, such as oral and eye-related symptoms, which may overlap with secondary Sjögren’s (sS). The objective of this research is to assess the ultrasound findings of lacrimal and salivary glands in patients with SLE and their association with relevant clinical and laboratory findings.

Methods: The study consisted of 76 patients with systemic lupus erythematosus, conducted in a cross-sectional manner. Ultrasound imaging of the lacrimal, submandibular, and parotid glands was conducted for every patient, with demographic characteristics, lab results, and clinical symptoms obtained from their medical records.

Results: Out of the 76 participants, 33 (41.5%) showed one or more oral symptoms linked to sS, while 23 (30.3%) reported experiencing dry eye. Half of the participants exhibited ultrasonographic abnormalities in salivary glands, while 52.6% showed heterogeneity in lacrimal glands. A significant correlation was found between dry eye symptoms and positive anti-Ro/SSA and anti-La/SSB serology and abnormal lacrimal/parotid ultrasound( P-value 0.036, 0.00 and 0.025 respectively). Notably, 88.9% of patients with a high suspicion of SS based on subjective symptoms and serology displayed abnormal ultrasonographic findings, suggesting the potential of SGUS and LGUS in early detection of secondary SS.

Conclusion: SGUS and LGUS are promising non-invasive modalities for the early detection of secondary SS in SLE patients. Their integration into routine clinical practice could facilitate timely diagnosis and intervention, potentially improving patient outcomes and quality of life.

Supporting image 1

Table 1. The demographic and clinical characteristics of the study participants

Supporting image 2

Table 2. Correlation between ultrasound results, lab tests, and sicca symptoms


Disclosures: M. Damirchi: None; N. Abdolahi: None; F. Hosseini: None; M. Mohammadi: None; M. Khosravi: None; Z. Niakan: None; S. Abbasi: None.

To cite this abstract in AMA style:

Damirchi M, Abdolahi N, Hosseini F, Mohammadi M, Khosravi M, Niakan Z, Abbasi S. Salivary and Lacrimal Glands Ultrasonography in Systemic Lupus Erythematosus Patients [abstract]. Arthritis Rheumatol. 2024; 76 (suppl 9). https://acrabstracts.org/abstract/salivary-and-lacrimal-glands-ultrasonography-in-systemic-lupus-erythematosus-patients/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2024

ACR Meeting Abstracts - https://acrabstracts.org/abstract/salivary-and-lacrimal-glands-ultrasonography-in-systemic-lupus-erythematosus-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology